|
1
|
Forner A, Llovet JM and Bruix J:
Hepatocellular carcinoma. Lancet. 379:1245–1255. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
El-Serag HB: Hepatocellular carcinoma. N
Engl J Med. 365:1118–1127. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Davis GL, Alter MJ, El-Serag H, Poynard T
and Jennings LW: Aging of hepatitis C virus (HCV)-infected persons
in the United States: A multiple cohort model of HCV prevalence and
disease progression. Gastroenterology. 138:513–521. 521.e511–516.
2010. View Article : Google Scholar
|
|
5
|
Parkin DM: The global health burden of
infection-associated cancers in the year 2002. Int J Cancer.
118:3030–3044. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ye S: Expert consensus on antiviral
therapy to treat hepatitis B/C virus-related hepatocellular
carcinoma. Zhonghua Gan Zang Bing Za Zhi. 22:321–326. 2014.In
Chinese. PubMed/NCBI
|
|
7
|
Balgi AD, Wang J, Cheng DY, Ma C, Pfeifer
TA, Shimizu Y, Anderson HJ, Pinto LH, Lamb RA, DeGrado WF, et al:
Inhibitors of the influenza A virus M2 proton channel discovered
using a high-throughput yeast growth restoration assay. PLoS One.
8:e552712013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Das K: Antivirals targeting influenza A
virus. J Med Chem. 55:6263–6277. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Cady SD, Schmidt-Rohr K, Wang J, Soto CS,
Degrado WF and Hong M: Structure of the amantadine binding site of
influenza M2 proton channels in lipid bilayers. Nature.
463:689–692. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lee JY, Oh S, Kim JM, Kim JS, Oh E, Kim
HT, Jeon BS and Cho JW: Intravenous amantadine on freezing of gait
in Parkinson's disease: A randomized controlled trial. J Neurol.
260:3030–3038. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Quarato G, Scrima R, Ripoli M, Agriesti F,
Moradpour D, Capitanio N and Piccoli C: Protective role of
amantadine in mitochondrial dysfunction and oxidative stress
mediated by hepatitis C virus protein expression. Biochem
Pharmacol. 89:545–556. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
StGelais C, Tuthill TJ, Clarke DS,
Rowlands DJ, Harris M and Griffin S: Inhibition of hepatitis C
virus p7 membrane channels in a liposome-based assay system.
Antiviral Res. 76:48–58. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lai CL and Yuen MF: Prevention of
hepatitis B virus-related hepatocellular carcinoma with antiviral
therapy. Hepatology. 57:399–408. 2013. View Article : Google Scholar
|
|
14
|
Kimer N, Dahl EK, Gluud LL and Krag A:
Antiviral therapy for prevention of hepatocellular carcinoma in
chronic hepatitis C: Systematic review and meta-analysis of
randomised controlled trials. BMJ Open. 2:22012. View Article : Google Scholar
|
|
15
|
Xiao F, Zhang W, Chen L, Chen F, Xie H,
Xing C, Yu X, Ding S, Chen K, Guo H, et al: MicroRNA-503 inhibits
the G1/S transition by downregulating cyclin D3 and E2F3 in
hepatocellular carcinoma. J Transl Med. 11:1952013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lamb R, Lehn S, Rogerson L, Clarke RB and
Landberg G: Cell cycle regulators cyclin D1 and CDK4/6 have
estrogen receptor-dependent divergent functions in breast cancer
migration and stem cell-like activity. Cell Cycle. 12:2384–2394.
2013. View
Article : Google Scholar : PubMed/NCBI
|
|
17
|
Vermeulen K, Van Bockstaele DR and
Berneman ZN: The cell cycle: A review of regulation, deregulation
and therapeutic targets in cancer. Cell Prolif. 36:131–149. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Murray AW: Recycling the cell cycle:
Cyclins revisited. Cell. 116:221–234. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Youn M-J, Kim JK, Park SY, Kim Y, Kim SJ,
Lee JS, Chai KY, Kim HJ, Cui MX, So HS, et al: Chaga mushroom
(Inonotus obliquus) induces G0/G1 arrest and apoptosis in human
hepatoma HepG2 cells. World J Gastroenterol. 14:511–517. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang RA, Li QL, Li ZS, Zheng PJ, Zhang HZ,
Huang XF, Chi SM, Yang AG and Cui R: Apoptosis drives cancer cells
proliferate and metastasize. J Cell Mol Med. 17:205–211. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Li X, Zhu Y, He H, Lou L, Ye W, Chen Y and
Wang J: Synergistically killing activity of aspirin and histone
deacetylase inhibitor valproic acid (VPA) on hepatocellular cancer
cells. Biochem Biophys Res Commun. 436:259–264. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Matsumoto H, Wada T, Fukunaga K, Yoshihiro
S, Matsuyama H and Naito K: Bax to Bcl-2 ratio and Ki-67 index are
useful predictors of neoadjuvant chemoradiation therapy in bladder
cancer. Jpn J Clin Oncol. 34:124–130. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Oshikawa T, Okamoto M, Ahmed SU, Tano T
and Sato M: The relationship between gene expression of Bcl-2 and
Bax and the therapeutic effect in oral cancer patients. Gan To
Kagaku Ryoho. 33:1723–1725. 2006.In Japanese.
|
|
24
|
Adhya AK, Srinivasan R and Patel FD:
Radiation therapy induced changes in apoptosis and its major
regulatory proteins, Bcl-2, Bcl-XL, and Bax, in locally advanced
invasive squamous cell carcinoma of the cervix. Int J Gynecol
Pathol. 25:281–287. 2006. View Article : Google Scholar : PubMed/NCBI
|
